Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2012

Open Access 01-12-2012 | Case report

A rare giant gastrointestinal stromal tumor of the stomach traversing the upper abdomen: a case report and literature review

Authors: Lei Zhou, Chang Liu, Ji-Gang Bai, Ji-Chao Wei, Kai Qu, Feng Tian, Ming-Hui Tai, Rui-Tao Wang, Fan-Di Meng

Published in: World Journal of Surgical Oncology | Issue 1/2012

Login to get access

Abstract

We present the case of a 66-year-old woman with a huge gastrointestinal stromal tumor of the stomach that traversed her upper abdomen. The predominant abdominal sign was a huge, palpable mass, but there were no other distinctive findings in her physical examination or her routine blood workup, including biochemical markers. It was difficult to judge the origin of the mass upon imaging. Furthermore, radiological findings revealed that the mass had a complex relationship with many major blood vessels. An exploratory laparotomy revealed a huge tumor protruding from the anterior wall of the stomach fundus, on the lesser curvature of the stomach, measuring approximately 21 × 34 × 11 cm in diameter and weighing 5.5 kg. A complete resection was performed and the tumor was characterized on immunohistochemistry as a gastrointestinal stromal tumor of the stomach. Preoperative diagnosis of gastrointestinal stromal tumors can be difficult, and we hope that the presentation of this rare case and literature review will benefit other diagnosing clinicians having similar problems.
Appendix
Available only for authorised users
Literature
1.
go back to reference Liegl-Atzwanger B, Fletcher JA, Fletcher CD: Gastrointestinal stromal tumors. Virchows Arch. 2010, 456: 111-127. 10.1007/s00428-010-0891-y.CrossRefPubMed Liegl-Atzwanger B, Fletcher JA, Fletcher CD: Gastrointestinal stromal tumors. Virchows Arch. 2010, 456: 111-127. 10.1007/s00428-010-0891-y.CrossRefPubMed
2.
go back to reference Miettinen M, Lasota J: Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006, 23: 70-83. 10.1053/j.semdp.2006.09.001.CrossRefPubMed Miettinen M, Lasota J: Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006, 23: 70-83. 10.1053/j.semdp.2006.09.001.CrossRefPubMed
3.
go back to reference Fülöp E, Marcu S, Milutin D, Borda A: Gastrointestinal stromal tumors: review on morphology, diagnosis and management. Rom J Morphol Embryol. 2009, 50: 319-326.PubMed Fülöp E, Marcu S, Milutin D, Borda A: Gastrointestinal stromal tumors: review on morphology, diagnosis and management. Rom J Morphol Embryol. 2009, 50: 319-326.PubMed
4.
go back to reference van der Zwan SM, DeMatteo RP: Gastrointestinal stromal tumor: 5 years later. Cancer. 2005, 104: 1781-1788. 10.1002/cncr.21419.CrossRefPubMed van der Zwan SM, DeMatteo RP: Gastrointestinal stromal tumor: 5 years later. Cancer. 2005, 104: 1781-1788. 10.1002/cncr.21419.CrossRefPubMed
5.
go back to reference Casali PG, Jost L, Reichardt P, Schlemmer M, Blay JY: Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008, 19 (2): 35-38. Casali PG, Jost L, Reichardt P, Schlemmer M, Blay JY: Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008, 19 (2): 35-38.
6.
go back to reference Kochlar R, Manoharan P, Leahy M, Taylor MB: Imaging in gastrointestinal stromal tumours: current status and future directions. Clin Radiol. 2010, 65: 584-592. 10.1016/j.crad.2010.02.006.CrossRef Kochlar R, Manoharan P, Leahy M, Taylor MB: Imaging in gastrointestinal stromal tumours: current status and future directions. Clin Radiol. 2010, 65: 584-592. 10.1016/j.crad.2010.02.006.CrossRef
7.
go back to reference Miettinen M, Lasota J: Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006, 130: 1466-1478.PubMed Miettinen M, Lasota J: Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006, 130: 1466-1478.PubMed
8.
go back to reference Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Tunio GM, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998, 279: 577-580. 10.1126/science.279.5350.577.CrossRefPubMed Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Tunio GM, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998, 279: 577-580. 10.1126/science.279.5350.577.CrossRefPubMed
9.
go back to reference Medinger M, Kleinschmidt M, Mross K, Wehmeyer B, Unger C, Schaefer HE, Weber R, Azemar M: c-kit (CD117) expression in human tumors and its prognostic value: an immunohistochemical analysis. Pathol Oncol Res. 2010, 16: 295-301. 10.1007/s12253-010-9247-9.CrossRefPubMed Medinger M, Kleinschmidt M, Mross K, Wehmeyer B, Unger C, Schaefer HE, Weber R, Azemar M: c-kit (CD117) expression in human tumors and its prognostic value: an immunohistochemical analysis. Pathol Oncol Res. 2010, 16: 295-301. 10.1007/s12253-010-9247-9.CrossRefPubMed
10.
go back to reference Medeiros F, Corless CL, Duensing A, Hornick JL, Oliveira AM, Heinrich MC, Fletcher JA, Fletcher CDM: KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol. 2004, 28: 889-894. 10.1097/00000478-200407000-00007.CrossRefPubMed Medeiros F, Corless CL, Duensing A, Hornick JL, Oliveira AM, Heinrich MC, Fletcher JA, Fletcher CDM: KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol. 2004, 28: 889-894. 10.1097/00000478-200407000-00007.CrossRefPubMed
11.
go back to reference Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CDM, Fletcher JA: PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003, 299: 708-710. 10.1126/science.1079666.CrossRefPubMed Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CDM, Fletcher JA: PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003, 299: 708-710. 10.1126/science.1079666.CrossRefPubMed
12.
go back to reference Miselli F, Millefanti C, Conca E, Negri T, Piacenza C, Pierotti MA, Tamborini E, Pilotti S: PDGFRA immunostaining can help in the diagnosis of gastrointestinal stromal tumors. Am J Surg Pathol. 2008, 32: 738-743. 10.1097/PAS.0b013e31815c47e8.CrossRefPubMed Miselli F, Millefanti C, Conca E, Negri T, Piacenza C, Pierotti MA, Tamborini E, Pilotti S: PDGFRA immunostaining can help in the diagnosis of gastrointestinal stromal tumors. Am J Surg Pathol. 2008, 32: 738-743. 10.1097/PAS.0b013e31815c47e8.CrossRefPubMed
13.
go back to reference Hostein I, Faur N, Primois C, Boury F, Denard J, Emile JF, Bringuier PP, Scoazec JY, Coindre JM: BRAF mutation status in gastrointestinal stromal tumors. Am J Clin Pathol. 2010, 133: 141-148. 10.1309/AJCPPCKGA2QGBJ1R.CrossRefPubMed Hostein I, Faur N, Primois C, Boury F, Denard J, Emile JF, Bringuier PP, Scoazec JY, Coindre JM: BRAF mutation status in gastrointestinal stromal tumors. Am J Clin Pathol. 2010, 133: 141-148. 10.1309/AJCPPCKGA2QGBJ1R.CrossRefPubMed
14.
go back to reference Abdel-Hadi M, Bessa SS, Hamam SM: Evaluation of the novel monoclonal antibody against DOG1 as a diagnostic marker for gastrointestinal stromal tumors. J Egypt Natl Canc Inst. 2009, 21: 237-247.PubMed Abdel-Hadi M, Bessa SS, Hamam SM: Evaluation of the novel monoclonal antibody against DOG1 as a diagnostic marker for gastrointestinal stromal tumors. J Egypt Natl Canc Inst. 2009, 21: 237-247.PubMed
15.
go back to reference Ou Wb, Zhu Mj, Demetri GD, Fletcher CDM, Fletcher JA: Protein kinase C-[theta] regulates KIT expression and proliferation in gastrointestinal stromal tumors. Oncogene. 2008, 27: 5624-5634. 10.1038/onc.2008.177.PubMedCentralCrossRefPubMed Ou Wb, Zhu Mj, Demetri GD, Fletcher CDM, Fletcher JA: Protein kinase C-[theta] regulates KIT expression and proliferation in gastrointestinal stromal tumors. Oncogene. 2008, 27: 5624-5634. 10.1038/onc.2008.177.PubMedCentralCrossRefPubMed
16.
go back to reference Parkkila S, Lasota J, Fletcher JA, Ou WB, Kivelä A, Nuorva K, Parkkila AK, Ollikainen J, Sly WS, Waheed A, Pastorekova S, Pastorek J, Isola J, Miettinen M: Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors. Mod Pathol. 2010, 23: 743-750. 10.1038/modpathol.2009.189.PubMedCentralCrossRefPubMed Parkkila S, Lasota J, Fletcher JA, Ou WB, Kivelä A, Nuorva K, Parkkila AK, Ollikainen J, Sly WS, Waheed A, Pastorekova S, Pastorek J, Isola J, Miettinen M: Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors. Mod Pathol. 2010, 23: 743-750. 10.1038/modpathol.2009.189.PubMedCentralCrossRefPubMed
17.
go back to reference Sepe PS, Brugge WR: A guide for the diagnosis and management of gastrointestinal stromal cell tumors. Nat Rev Gastroenterol Hepatol. 2009, 6: 363-371. 10.1038/nrgastro.2009.43.CrossRefPubMed Sepe PS, Brugge WR: A guide for the diagnosis and management of gastrointestinal stromal cell tumors. Nat Rev Gastroenterol Hepatol. 2009, 6: 363-371. 10.1038/nrgastro.2009.43.CrossRefPubMed
18.
go back to reference Cohen MH, Farrell A, Justice R, Pazdur R: Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Oncologist. 2009, 14: 174-180. 10.1634/theoncologist.2008-0255.CrossRefPubMed Cohen MH, Farrell A, Justice R, Pazdur R: Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Oncologist. 2009, 14: 174-180. 10.1634/theoncologist.2008-0255.CrossRefPubMed
19.
go back to reference Demetri GD, Heinrich MC, Fletcher JA, Fletcher CDM, Van den Abbeele AD, Corless CL, Antonescu CR, George S, Morgan JA, Chen MH, Bello CL, Huang X, Cohen DP, Baum CM, Maki RG: Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure. Clin Cancer Res. 2009, 15: 5902-5909. 10.1158/1078-0432.CCR-09-0482.PubMedCentralCrossRefPubMed Demetri GD, Heinrich MC, Fletcher JA, Fletcher CDM, Van den Abbeele AD, Corless CL, Antonescu CR, George S, Morgan JA, Chen MH, Bello CL, Huang X, Cohen DP, Baum CM, Maki RG: Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure. Clin Cancer Res. 2009, 15: 5902-5909. 10.1158/1078-0432.CCR-09-0482.PubMedCentralCrossRefPubMed
20.
go back to reference Montemurro M, Schoffski P, Reichardt P, Gelderblom H, Schütte J, Hartmann JT, Moos RV, Seddon B, Joensuu H, Wendtner CM, Weber E, Grünwald V, Roth A, Leyvraz S: Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. Eur J Cancer. 2009, 45: 1959-1968. 10.1016/j.ejca.2009.02.011.CrossRef Montemurro M, Schoffski P, Reichardt P, Gelderblom H, Schütte J, Hartmann JT, Moos RV, Seddon B, Joensuu H, Wendtner CM, Weber E, Grünwald V, Roth A, Leyvraz S: Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. Eur J Cancer. 2009, 45: 1959-1968. 10.1016/j.ejca.2009.02.011.CrossRef
21.
go back to reference Fletcher CDM, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’ Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW: Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002, 33: 459-465. 10.1053/hupa.2002.123545.CrossRefPubMed Fletcher CDM, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’ Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW: Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002, 33: 459-465. 10.1053/hupa.2002.123545.CrossRefPubMed
22.
go back to reference Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, Pisters PWT, Raut CP, Riedel RF, Schuetze S, Sundar HM, Trent JC, Wayne JD: NCCN task force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010, 8 (Suppl 2): S1-S41.PubMedCentralPubMed Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, Pisters PWT, Raut CP, Riedel RF, Schuetze S, Sundar HM, Trent JC, Wayne JD: NCCN task force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010, 8 (Suppl 2): S1-S41.PubMedCentralPubMed
Metadata
Title
A rare giant gastrointestinal stromal tumor of the stomach traversing the upper abdomen: a case report and literature review
Authors
Lei Zhou
Chang Liu
Ji-Gang Bai
Ji-Chao Wei
Kai Qu
Feng Tian
Ming-Hui Tai
Rui-Tao Wang
Fan-Di Meng
Publication date
01-12-2012
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2012
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-10-66

Other articles of this Issue 1/2012

World Journal of Surgical Oncology 1/2012 Go to the issue